Correcting Disinformation About Menthol Cigarettes and Flavored Cigars
Ориентир для пациента и семьи
Простыми словами
Автоматическая сводка по структурированным данным реестра. Она помогает сориентироваться, но не заменяет официальный протокол или оценку врача.
- Что изучают
- В протоколе указаны: Individual delivery of anti-disinformation messaging, Community delivery of anti-disinformation messaging.
- Кому может быть актуально
- Состояния в реестре: Disinformation, Menthol Cigarettes, Flavored Cigars. Базовые параметры: от 18 лет · Все.
- Что важно проверить
- Возраст, диагноз и пол — только базовые ориентиры. Предыдущее лечение, анализы и другие обязательные условия указаны ниже в критериях участия.
- Где проводится
- США
- Следующий шаг
- Сохраните исследование, покажите его лечащему врачу и уточните актуальный статус у исследовательского центра. Расходы, документы и поездка →
Не всё понятно в терминах? Прочитайте наш гид для пациентов →
Официальное название
The Unvarnished Truth: Pursuing Health Equity by Correcting Disinformation Targeting African Americans About the FDA's Proposed Ban on Menthol Cigarettes and Flavored Cigars
Обзор
Our study tests a multi-level anti- disinformation message (ADM) campaign on menthol cigarette and flavored cigar policies in Black adults.
Подробное описание
This study uses a prospective, randomized factorial trial design to evaluate delivery of anti-disinformation messaging (ADM) on Black adults' receptivity to flavored tobacco policies, beliefs about the tobacco industry, and beliefs about menthol cigarettes and flavored cigars. Eligible, consenting participants will complete the baseline survey, providing sociodemographic information and baseline measures of study outcomes. Participants will then be randomized, stratified by study site (Atlanta, GA or Birmingham, AL), in a 1:1 ratio within the survey platform to either the individually-delivered ADM intervention or control condition. Participants in the intervention condition (Intervention-I) will receive their first exposure to the ADM intervention at the end of baseline survey. At follow-up assessments (3-months, 6-months, 9-months, 12-months), all participants will complete study measures and at 3-, 6-, and 9-month follow-up assessments, Intervention-I participants will be exposed to the ADM intervention at the end of the survey. Six months after our first enrollment in the trial, Atlanta will receive the community-delivered ADM intervention, while Birmingham serves as the control community. Community partners in Atlanta, our Intervention Community (Intervention-C), will disseminate our ADM intervention messages through their community networks for 12 months, overlapping at least six months with the delivery of the individual-level intervention (Intervention-I) in our enrolled participants. Upon completion of the final assessment (12-month follow-up), all participants will be exposed to the ADM intervention within the survey platform and asked to complete measures on perceived message effectiveness and credibility of the study messages.
Вмешательства
- Поведенческое Individual delivery of anti-disinformation messaging
Participants in this condition will be exposed to anti-disinformation messages (ADM) designed to increase correct beliefs about menthol cigarettes, flavored cigars, the purpose, and limits of flavored tobacco policies. The delayed intervention control condition in this study will receive the ADM intervention after outcome measures are collected at the last assessment. - Поведенческое Community delivery of anti-disinformation messaging
Our community-level campaign will distribute our ADM messages to our Intervention Community via social media, print ads and posters, radio ads, and community events. These messages will be delivered over 1 year, with monthly delivery activities led by EAB members in the Intervention Community.
Первичные конечные точки
- Proportion of participants with specific tobacco industry beliefs [Срок оценки: 3, 6, 9, 12 months]
- Knowledge about menthol cigarettes and flavored cigars [Срок оценки: 3, 6, 9, 12 months]
- Knowledge of flavored tobacco policies [Срок оценки: 3, 6, 9, 12 months]
Вторичные конечные точки (1)
- Intention to support flavored tobacco policies [Срок оценки: 3, 6, 9, 12 months]
Критерии участия
Критерии включения
- African American or Black adults
- Aged 18+
- Reside in Atlanta, GA or Birmingham, AL
- Able to read and speak English
- Willing to engage in all online study activities including online quarterly surveys over a 12-month period.
Критерии исключения
\-
Критерии приведены из реестра в оригинале (на английском). Окончательную оценку соответствия проводит исследовательский центр.
Здоровые добровольцы: Да
Дизайн исследования
- Распределение
- Рандомизированное
- Модель
- Факторный дизайн
- Маскирование
- Открытое
- Основная цель
- Фундаментальное исследование
Центры проведения
США · 1 центр
- Rutgers University — New Brunswick
Публикации
- Ganz O, Villanti AC, Altunbilek A, Johnson A, Garmon J, Wackowski OA, Sterling KL. Tobacco Company Efforts to Persuade Consumers to Fight the Proposed Federal Menthol Cigarette and Flavored Cigar Bans in the United States. Am J Public Health. 2025 Aug;115(8):1206-1210. doi: 10.2105/AJPH.2025.308116. No abstract available. PMID 40633013
- Wackowski OA, Garmon J, Altunbilek A, Johnson A, Ganz O, Ntansah CA, Fryer CS, Villanti AC, Sterling KL. News Coverage of the Proposed Menthol Cigarette Ban in the United States (2022-2024) - a Content Analysis. Nicotine Tob Res. 2026 Feb 18:ntag036. doi: 10.1093/ntr/ntag036. Online ahead of print. PMID 41705314
- Garmon J, Sterling K, Wackowski OA, Ganz O, Allem JP, Villanti AC. Funding without transparency? Tobacco company support of Black-owned businesses in the USA. Tob Control. 2024 Nov 19:tc-2024-058721. doi: 10.1136/tc-2024-058721. Online ahead of print. No abstract available. PMID 39561998
- Sterling KL, Ganz O, Wackowski OA, Glasser AM, Villanti AC. Widespread Misperceptions Among U.S. Adults About Tobacco Company Engagement in Black and African American Communities. Nicotine Tob Res. 2025 Mar 24;27(4):741-747. doi: 10.1093/ntr/ntae066. PMID 38692654
Идентификаторы
NCT: NCT07543081 · Pro2023001258 · R01MD018728